Authored By: Sarah
29 Aug 2023

Gene Therapy Market Share to Grow by USD 4,613.9 Million at a CAGR of 19.91% Between 2022 and 2027

The gene therapy market share is forecast to reach USD 4,613.9 million, after growing at a CAGR of 19.91% during 2023-2027. The increase in special drug designations is analyzed to boost the gene therapy market growth. Moreover, Growing research in gene therapy for CVDs and orphan diseases is the major trend enhancing the overall market demand for gene therapy during the forecast period.   

Get a snapshot of the gene therapy market analysis: Unlock the Sample Report The report includes historic market data from 2017 to 2021. In 2017, the market was valued at USD 1718.08 Million.

Browse Technavio's 161-page report and in-depth TOC on "Gene Therapy Market by therapy area (oncology, CNS, ophthalmology, rare diseases, and others), delivery mode (in vivo and ex vivo), and geography (North America, Europe, Asia, and Rest of World (ROW)).

View detailed Table of Contents Here: https://www.technavio.com/report/gene-therapy-market-industry-analysis

Gene Therapy Market Share to Grow by USD 4,613.9 Million at a CAGR of 19.91% Between 2022 and 2027

Therapy area: 

  • Oncology: The market share growth by the oncology segment will be significant during the forecast period. In this segment, owing to the high success rate of treatment using gene therapy, many companies are focusing on developing novel gene therapies. 

  • CNS

  • Ophthalmology

  • Rare diseases

Geography: 

  • North America: 39% of market growth will develop from North America during the forecast period. The launch of new products, the rising number of M and A activities, and the increasing pipeline products will boost the growth of the cell and gene therapy market in North America during the forecast period. 

  • Europe 

  • Asia 

  • Rest of World (ROW) 

Delivery Mode : 

  • In vivo 

  • Ex vivo

Key Takeaways: 

  • The gene therapy market size will witness a YOY Growth Rate of 16.76% in 2023.  

  • The high treatment cost will be a major challenge for the gene therapy market during the forecast period. 

  • Major key gene therapy market players include: Abeona Therapeutics Inc., Adaptimmune Therapeutics plc, Adverum Biotechnologies Inc., Amgen Inc., Astellas Pharma Inc., Biogen Inc., bluebird bio Inc., Editas Medicine Inc., ElevateBio, F. Hoffmann La Roche Ltd., Generation Bio Co., Gilead Sciences Inc., Novartis AG, Orchard Therapeutics Plc, Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Sibiono GeneTech Co. Ltd., Syncona Ltd., uniQure NV, and Voyager Therapeutics Inc.

  • The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as the North America, Europe, Asia, and Rest of World (ROW). 

Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth. 

Key data covered in the Gene Therapy Market report 

  • Precise market size estimation during the forecast period 2023-2027.  

  • CAGR of the gene therapy market forecast during 2023-2027.  

  • Market-level data on units, average selling prices, and values of the gene therapy market share.  

  • Prediction of the upcoming trends, drivers, and factors that challenge the growth of the gene therapy market.  

  • Gene therapy industry growth across North America, Europe, Asia, and Rest of World (ROW).

Read News Read Less
Interested in this report?
Get your sample now!
Technavio